Healthcare spending in US slowsLos Angeles Times, CA - 1 hour agoThe shift to generics has accelerated as a number of blockbuster medications, including Zocor, Flonase and Ambien, lost patent protection in 2006 and 2007. ... |
TO THE POINTInvestor's Business Daily (subscription) - 6 hours agoThe drug makers settled a patent dispute over the blood disorder drug Soliris. PDL BioPharma (PDLI) had claimed patent infringement by Alexion ... |
Drug Abuse BasicsScienceBlogs - 8 hours agoPatent medicine era of the late nineteenth century? You bet. So for those of you who think that, duh, of course heroin and cigarettes produce dependence of ... |
Endo Shifts Gears With IndevusForbes, NY - 9 hours agoThe pharmaceutical company expects to up to $40.0 million in cost savings. Shares of Indevus jumped 73.8%, or $2.30, to trade at $5.40, in after-hours ... |
Prism Pharmaceuticals arrythmia drug OK’dBizjournals.com, NC - 10 hours agoThe drug — Prism’s first to get FDA approval — is a patent-protected, cosolvent-free formulation of the antiarrhythmic agent Amiodarone IV, ... |
This entry was posted
on Friday, November 7th, 2008 at 11:20 pm and is filed under Uncategorized.
You can follow any responses to this entry through the RSS 2.0 feed.
Responses are currently closed, but you can trackback from your own site.